Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 2 |
2005 | 3 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients.
Clin Pharmacokinet. 2005;44(5):495-507. doi: 10.2165/00003088-200544050-00003.
Clin Pharmacokinet. 2005.
PMID: 15871635
Clinical Trial.
Pharmacodynamics of oral ganciclovir and valganciclovir in solid organ transplant recipients.
Wiltshire H, Paya CV, Pescovitz MD, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Freeman R, Heaton N, Zuideveld KP; Valganciclovir Solid Organ Transplant Study Group.
Wiltshire H, et al.
Transplantation. 2005 Jun 15;79(11):1477-83. doi: 10.1097/01.tp.0000164512.99703.ad.
Transplantation. 2005.
PMID: 15940035
Clinical Trial.
Item in Clipboard
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients.
Paya C, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Freeman R, Heaton N, Pescovitz MD; Valganciclovir Solid Organ Transplant Study Group.
Paya C, et al.
Am J Transplant. 2004 Apr;4(4):611-20. doi: 10.1111/j.1600-6143.2004.00382.x.
Am J Transplant. 2004.
PMID: 15023154
Free article.
Clinical Trial.
Item in Clipboard
Risk factors for cytomegalovirus viremia and disease developing after prophylaxis in high-risk solid-organ transplant recipients.
Freeman RB, Paya C, Pescovitz MD, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Heaton N; Valganciclovir Solid Organ Transplant Study Group.
Freeman RB, et al.
Transplantation. 2004 Dec 27;78(12):1765-73. doi: 10.1097/01.tp.0000142619.01510.a5.
Transplantation. 2004.
PMID: 15614149
Clinical Trial.
Item in Clipboard
Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients.
Humar A, Mazzulli T, Moussa G, Razonable RR, Paya CV, Pescovitz MD, Covington E, Alecock E; Valganciclovir Solid Organ Transplant Study Group.
Humar A, et al.
Am J Transplant. 2005 May;5(5):1065-70. doi: 10.1111/j.1600-6143.2005.00797.x.
Am J Transplant. 2005.
PMID: 15816887
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite